Skip to main content
Clinical Trials/NCT06609967
NCT06609967
Completed
N/A

Effect of Autologous Platelet Rich Fibrin (PRF) on Post-Operative Complications and Healing Following the Extractions Impacted Mandibular Wisdoms

Dow University of Health Sciences1 site in 1 country30 target enrollmentNovember 15, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pain, Postoperative
Sponsor
Dow University of Health Sciences
Enrollment
30
Locations
1
Primary Endpoint
Pain
Status
Completed
Last Updated
last year

Overview

Brief Summary

As post-operative pain, infection inflammation and infections are the main complications after the surgical extraction of the lower third molar the aim of this study is to compare the healing effects of PRF administered postoperatively

Detailed Description

PRF will be randomly administered into one group of patients undergoing any extractions group A (Right after the extraction) Group B will be a control group in which extraction sockets will be left to heal with the natural blood clot. Consenting patients will be assigned into groups randomly and not informed which group they were placed into. The PRF will be administered obtained from a tube of 10 ml blood and no material will be placed in the control group. The progress of healing and post-operative complications will be tracked over a period of 7 days with patients being called for follow-up on days 3, 5 and 7. Their post-operative complications will be checked at every subsequent visit and noted in the questionnaire. The Questionnaire is structured and will be interviewer-administered. It will comprise of basic bio-demographic data (such as name, age, sex, etc) and 3 closed-ended questions related to post-operative complications following the extraction

Registry
clinicaltrials.gov
Start Date
November 15, 2021
End Date
August 30, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hamza Jawed

Principal Investigator

Dow University of Health Sciences

Eligibility Criteria

Inclusion Criteria

  • Both male and female patients
  • Patients that give their consent to the use of their information and to the administration of the drug will be the participants of the study.
  • Patients with 3rd molar impactions
  • Absence of systemic diseases
  • age ⩾18 years and the ability to cooperate with the requirements of the study protocol.

Exclusion Criteria

  • Medically compromised patients.
  • Immunocompromised patients.
  • Patients that do not consent.
  • Patients that are below the age of
  • Patients that are pregnant.
  • Fully erupted molars will be excluded. smokers (\> 5 a day) will be excluded as well.

Outcomes

Primary Outcomes

Pain

Time Frame: 7 days

Post-operative pain will be measured using a visual analog scale in both groups i.e. conventional therapy group and PRF group on the 1st, 3rd and 7th post operative day.

Post operative Swelling

Time Frame: 7 days

Post operative swelling will be measured in terms of metric calculation (centimeters) in 2 sites i.e: 1. From the tragus of the ear to angle of mouth and 2. From lateral canthus of eye to angle of mandible on the 3rd and 7th post operative day.

Trismus- Post surgical limitation in mouth opening

Time Frame: 7 days

Trismus will be measured as the distance in (cm) between the edges of the maxillary and mandibular central incisors post surgically on the 3rd and 7th post operative day.

Wound/ extraction socket healing

Time Frame: 7 days

The wound healing of the extraction socket of mandibular wisdom teeth will be assessed according to Landry\'s criteria on the 7th post operative day.

Study Sites (1)

Loading locations...

Similar Trials